These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8877267)

  • 1. Ongoing risk stratification trials: the primary prevention of sudden death.
    Buxton AE
    Control Clin Trials; 1996 Jun; 17(3 Suppl):47S-51S. PubMed ID: 8877267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The implantable cardioverter defibrillator and primary prevention of sudden death: the Multicenter Automatic Defibrillator Implantation Trial and the Coronary Artery Bypass Graft (CABG)-Patch Trial.
    Block M; Breithardt G
    Am J Cardiol; 1999 Mar; 83(5B):74D-78D. PubMed ID: 10089844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.
    Buxton AE; Lee KL; Fisher JD; Josephson ME; Prystowsky EN; Hafley G
    N Engl J Med; 1999 Dec; 341(25):1882-90. PubMed ID: 10601507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic implantable cardioverter defibrillator trials: MUSTT, MADIT, and beyond. Multicenter Unsustained Tachycardia Trial. Multicenter Automatic Defibrillator Implantation Trial.
    Prystowsky EN; Nisam S
    Am J Cardiol; 2000 Dec; 86(11):1214-5, A5. PubMed ID: 11090794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing sudden death in coronary cardiomyopathy: implantable defibrillators lead the way.
    Pavia S; Wilkoff BL
    Cleve Clin J Med; 2001 Feb; 68(2):113, 118, 120, 121, 125, 129. PubMed ID: 11220454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
    Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
    Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary prevention of sudden death with implantable defibrillator therapy in patients with cardiac disease: Can we afford to do it? (Can we afford not to?).
    Exner DV; Klein GJ; Prystowsky EN
    Circulation; 2001 Sep; 104(13):1564-70. PubMed ID: 11571253
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms of death in the CABG Patch trial: a randomized trial of implantable cardiac defibrillator prophylaxis in patients at high risk of death after coronary artery bypass graft surgery.
    Bigger JT; Whang W; Rottman JN; Kleiger RE; Gottlieb CD; Namerow PB; Steinman RC; Estes NA
    Circulation; 1999 Mar; 99(11):1416-21. PubMed ID: 10086963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of implantable cardioverter-defibrillators.
    Sanders GD; Hlatky MA; Owens DK
    N Engl J Med; 2005 Oct; 353(14):1471-80. PubMed ID: 16207849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.
    Klein H; Auricchio A; Reek S; Geller C
    Am J Cardiol; 1999 Mar; 83(5B):91D-97D. PubMed ID: 10089848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing sudden cardiac death.
    Calkins H
    Health News; 2000 Jan; 6(1):3. PubMed ID: 11019657
    [No Abstract]   [Full Text] [Related]  

  • 12. Baseline characteristics of patients in the coronary artery bypass graft (CABG) Patch Trial.
    Curtis AB; Cannom DS; Bigger JT; DiMarco JP; Estes NA; Steinman RC; Parides MK
    Am Heart J; 1997 Nov; 134(5 Pt 1):787-98. PubMed ID: 9398090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designation and distribution of events in the Multicenter UnSustained Tachycardia Trial (MUSTT).
    Fisher JD; Buxton AE; Lee KL; Packer DL; Echt DS; Denes P; Lehmann MH; DiMarco JP; Roy D; Hafley GE;
    Am J Cardiol; 2007 Jul; 100(1):76-83. PubMed ID: 17599445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening and therapy for patients with nonsustained ventricular tachycardia.
    Prystowsky EN
    Am J Cardiol; 2000 Nov; 86(9A):34K-39K. PubMed ID: 11084098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of sudden death in patients with coronary artery disease.
    Aggarwal A
    N Engl J Med; 2000 Apr; 342(17):1291; author reply 1291-2. PubMed ID: 10787333
    [No Abstract]   [Full Text] [Related]  

  • 16. Implantable cardioverter defibrillators in the United States: understanding the benefits and limitations of implantable cardioverter defibrillator therapy based on clinical trial results.
    Gottlieb C; Callans DJ; Marchlinski F
    Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 1):2016-20. PubMed ID: 9826851
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of sudden death in patients with coronary artery disease.
    Bloom JM
    N Engl J Med; 2000 Apr; 342(17):1291-2. PubMed ID: 10787334
    [No Abstract]   [Full Text] [Related]  

  • 18. [A randomized study of the prevention of sudden death in patients with coronary heart disease].
    Elvas L
    Rev Port Cardiol; 2000 Feb; 19(2):271-3. PubMed ID: 10763358
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of the implantable cardioverter-defibrillator for prevention of sudden cardiac death.
    Josephson ME; Callans DJ; Buxton AE
    Ann Intern Med; 2000 Dec; 133(11):901-10. PubMed ID: 11103061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary prevention of sudden cardiac death with implantable cardioverter defibrillators: lessons learned from MADIT and MUSTT.
    Gold MR; Nisam S;
    Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):1981-5. PubMed ID: 11139972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.